Report cover image

NA Sarcopenia Treatment Market - Industry Trends and Forecast to 2034

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 166 Pages
SKU # DAABD18360522

Description

NA Sarcopenia Treatment Market - Industry Trends and Forecast to 2034


The North America sarcopenia treatment market is expected to reach USD 1,814,892.90 thousand by 2030 from USD 1,235,920.05 thousand in 2022, growing at a CAGR of 5.0% in the forecast period of 2023 to 2030.
Market Segmentation
North America Sarcopenia Treatment Market, By Treatment Type (Medications, Vitamin/Dietary Supplements, and Others), Type (Primary Sarcopenia and Secondary Sarcopenia), Stages (Pre-Sarcopenia, Sarcopenia, and Severe Sarcopenia), Route Of Administration (Oral, Injectable, and Others), Gender (Male and Female), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico,) - Industry Trends and Forecast to 2030

Overview of North America Sarcopenia Treatment Market Dynamics

Driver
• Rising prevalence of sarcopenia

Restraint

• Lack of standardized diagnosis

Opportunity

• Strategic initiatives by key market players

Market Players

Some of the key market players operating in the North America sarcopenia treatment market are listed below:
• Abbott
• Nestlé Health Science (A subsidiary of Nestlé S.A.)
• Novartis AG
• Sanofi
• Haleon Group of Companies
• BASF SE
• DSM
• Fermenta Biotech Limited
• AstaReal Co., Ltd.
• Metagenics
• BioThrive Sciences
• Wellona Pharma
• The Vitamin Company India
• Healing Pharma India Pvt. Ltd
• Others

Table of Contents

166 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Sarcopenia Treatment Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Treatment Type Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces Model
4.3 Current Status Of Emerging Drugs For Sarcopenia Treatment
5 North America Sarcopenia Treatment Market: Regulations
5.1 Regulations In U.S.
5.2 Regulations In Europe
5.3 Regulations In Australia
5.4 Regulations In South Africa
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Sarcopenia
6.1.2 Growing Awareness Of Sarcopenia And Its Detrimental Effects On Health
6.1.3 Lifestyle Factors Such As Poor Nutrition And Sedentary Behaviour
6.2 Restraints
6.2.1 Lack Of Standardized Diagnosis
6.2.2 High Cost Of Treatment And Interventions
6.3 Opportunities
6.3.1 Strategic Initiatives By Market Players
6.3.2 Increasing Research And Development Activities
6.4 Challenges
6.4.1 Complications Associated With The Sarcopenia Treatment
6.4.2 Stringent Government Rules And Regulation For Product Approval
7 North America Sarcopenia Treatment Market, By Treatment Type
7.1 Overview
7.2 Vitamin/Dietary Supplements
7.2.1 Vitamin Supplements
7.2.2 Protein Supplements
7.2.3 Fatty Acid Supplements
7.2.4 Creatine
7.2.5 Whey Proteins
7.2.6 L-carnitine
7.2.7 Soy
7.2.8 Beta-alanine
7.2.9 Ostarine
7.2.10 Collagen Peptides
7.2.11 Ligandrol
7.2.12 Branch-chain Amino Acids
7.2.13 Hydroxymethylbutyrate (Hmb)
7.2.14 Medium Chain Triglycerides
7.2.15 Others
7.3 Medications
7.3.1 Off Label Drugs
7.3.2 Emerging Drugs
7.3.2.1 Ace Inhibitors
7.3.2.2 Appetite Stimulants
7.3.2.3 Oral Antidiabetic Drugs
7.3.2.4 Others
7.4 Others 8 North America Sarcopenia Treatment Market, By Type
8.1 Overview
8.2 Primary Sarcopenia
8.2.1 Vitamin/Dietary Supplements
8.2.2 Medications
8.2.3 Others
8.3 Secondary Sarcopenia
8.3.1 Vitamin/Dietary Supplements
8.3.2 Medications
8.3.3 Others
9 North America Sarcopenia Treatment Market, By Stages
9.1 Overview
9.2 Pre-sarcopenia
9.3 Sarcopenia
9.4 Severe Sarcopenia
10 North America Sarcopenia Treatment Market, By Route Of Administration
10.1 Overview
10.2 Oral
10.3 Injectables
10.4 Others
11 North America Sarcopenia Treatment Market, By Gender
11.1 Overview
11.2 Male
11.3 Female
12 North America Sarcopenia Treatment Market, By End User
12.1 Overview
12.2 Hospitals
12.2.1 Public
12.2.2 Private
12.3 Specialty Clinics
12.4 Home Healthcare
12.5 Others 13 North America Sarcopenia Treatment Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Retail Sales
13.3.1 Hospital Pharmacies
13.3.2 Online Pharmacies
13.3.3 Others
13.4 Others
14 North America Sarcopenia Treatment Market, By Region
14.1 North America
14.1.1 U.S.
14.1.2 Canada
14.1.3 Mexico
15 North America Sarcopenia Treatment Market, Company Landscape
15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile
17.1 Abbott
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.2 Nestlé Health Science (A Subsidiary Of Nestlé S.A.)
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Novartis Ag
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Pipeline Portfolio
17.3.6 Recent Development
17.4 Sanofi
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Haleon Group Of Companies.
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Development
17.6 Astareal Co., Ltd.
17.6.1 Company Snapshot
17.6.2 Product Portfolio
17.6.3 Recent Development
17.7 Basf Se
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Biogen Sa
17.8.1 Company Snapshot
17.8.2 Product Portfolio
17.8.3 Recent Development
17.9 Biothrive Sciences
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Dsm
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Development
17.11 Fermenta Biotech Limited
17.11.1 Company Snapshot
17.11.2 Revenue Analysis
17.11.3 Product Portfolio
17.11.4 Recent Development 17.12 Healing Pharma India Pvt. Ltd.
17.12.1 Company Snapshot
17.12.2 Product Portfolio
17.12.3 Recent Development
17.13 Metagenics
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 The Vitamin Company India
17.14.1 Company Snapshot
17.14.2 Product Portfolio
17.14.3 Recent Development
17.15 Wellona Pharma
17.15.1 Company Snapshot
17.15.2 Product Portfolio
17.15.3 Recent Development
17.16 Armgo Pharma, Inc.
17.16.1 Company Snapshot
17.16.2 Pipeline Portfolio
17.16.3 Recent Development
17.17 Biophytis
17.17.1 Company Snapshot
17.17.2 Pipeline Portfolio
17.17.3 Recent Development
17.18 Dystrogen Therapeutics Corp
17.18.1 Company Snapshot
17.18.2 Pipeline Portfolio
17.18.3 Recent Development
17.19 Immunoforge Inc.
17.19.1 Company Snapshot
17.19.2 Pipeline Portfolio
17.19.3 Recent Development
17.20 Mymd Pharmaceuticals
17.20.1 Company Snapshot
17.20.2 Pipeline Portfolio
17.20.3 Recent Development
17.21 Nmd Pharma A/S
17.21.1 Company Snapshot
17.21.2 Pipeline Portfolio
17.21.3 Recent Development
17.22 Oncocross Co., Ltd.
17.22.1 Company Snapshot
17.22.2 Pipeline Portfolio
17.22.3 Recent Development
17.23 Opko Health, Inc.
17.23.1 Company Snapshot
17.23.2 Revenue Analysis
17.23.3 Pipeline Portfolio
17.23.4 Recent Development
17.24 Regeneron Pharmaceuticals Inc.
17.24.1 Company Snapshot
17.24.2 Revenue Analysis
17.24.3 Pipeline Portfolio
17.24.4 Recent Development
17.25 Rejuvenate Biomed Nv
17.25.1 Company Snapshot
17.25.2 Pipeline Portfolio
17.25.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 Current Status Of The Development Of Drug For Sarcopenia Treatment
Table 2 North America Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 3 North America Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 4 North America Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 5 North America Medications In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 6 North America Medicatinons In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 7 North America Off-lable Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 8 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 9 North America Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 10 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 11 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 12 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 13 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 14 North America Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 15 North America Pre-sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 16 North America Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 17 North America Severe Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 18 North America Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 19 North America Oral In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 20 North America Injectables In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 21 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 22 North America Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 23 North America Male In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 24 North America Female In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 25 North America Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 26 North America Hospitals In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 27 North America Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 28 North America Specialty Clinics In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 29 North America Home Healthcare In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 30 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 31 North America Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 32 North America Direct Tender In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 33 North America Retail Sales In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 34 North America Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 35 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 36 North America Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 37 North America Sarcopenia Treatment Market, By Country, 2021-2030 (Usd Thousand)
Table 38 North America Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 39 North America Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 40 North America Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 41 North America Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 42 North America Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 43 North America Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 44 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 45 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 46 North America Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 47 North America Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 48 North America Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 49 North America Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 50 North America Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 51 North America Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 52 North America Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 53 U.S. Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 54 U.S. Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 55 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 56 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 57 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 58 U.S. Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 59 U.S. Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 60 U.S. Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 61 U.S. Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 62 U.S. Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 63 U.S. Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 64 U.S. Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 65 U.S. Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 66 U.S. Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 67 U.S. Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 68 U.S. Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 69 Canada Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 70 Canada Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 71 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 72 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 73 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 74 Canada Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 75 Canada Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 76 Canada Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 77 Canada Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 78 Canada Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 79 Canada Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 80 Canada Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 81 Canada Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 82 Canada Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 83 Canada Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 84 Canada Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 85 Mexico Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 86 Mexico Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 87 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 88 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 89 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 90 Mexico Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 91 Mexico Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 92 Mexico Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 93 Mexico Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 94 Mexico Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 95 Mexico Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 96 Mexico Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 97 Mexico Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 98 Mexico Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 99 Mexico Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 100 Mexico Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 North America Sarcopenia Treatment Market: Segmentation
Figure 2 North America Sarcopenia Treatment Market: Data Triangulation
Figure 3 North America Sarcopenia Treatment Market: Droc Analysis
Figure 4 North America Sarcopenia Treatment Market: North America Vs Regional Market Analysis
Figure 5 North America Sarcopenia Treatment Market: Company Research Analysis
Figure 6 North America Sarcopenia Treatment Market: Interview Demographics
Figure 7 North America Sarcopenia Treatment Market: Market End Users Coverage Grid
Figure 8 North America Sarcopenia Treatment Market: Dbmr Market Position Grid
Figure 9 North America Sarcopenia Treatment Market: Vendor Share Analysis
Figure 10 North America Sarcopenia Treatment Market: Segmentation
Figure 11 The Rising Prevalence Of Sarcopenia And Growing Awareness Of Sarcoepnia And Its Detrimental Effect On Health Are Expected To Drive The Growth Of The North America Sarcopenia Treatment Market From 2023 To 2030
Figure 12 Vitamin/Dietary Supplements Segment Is Expected To Account For The Largest Share Of The North America Preclinical Market In 2023 And 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Sarcopenia Treatment Market
Figure 14 North America Sarcopenia Treatment Market: By Treatment Type, 2022
Figure 15 North America Sarcopenia Treatment Market: By Treatment Type, 2023-2030 (Usd Thousand)
Figure 16 North America Sarcopenia Treatment Market: By Treatment Type, Cagr (2023-2030)
Figure 17 North America Sarcopenia Treatment Market: By Treatment, Lifeline Curve
Figure 18 North America Sarcopenia Treatment Market: By Type, 2022
Figure 19 North America Sarcopenia Treatment Market: By Type, 2023-2030 (Usd Thousand)
Figure 20 North America Sarcopenia Treatment Market: By Type, Cagr (2023-2030)
Figure 21 North America Sarcopenia Treatment Market: By Type, Lifeline Curve
Figure 22 North America Sarcopenia Treatment Market: By Stages, 2022
Figure 23 North America Sarcopenia Treatment Market: By Stages, 2023-2030 (Usd Thousand)
Figure 24 North America Sarcopenia Treatment Market: By Stages, Cagr (2023-2030)
Figure 25 North America Sarcopenia Treatment Market: By Stages, Lifeline Curve
Figure 26 North America Sarcopenia Treatment Market: By Route Of Administration, 2022
Figure 27 North America Sarcopenia Treatment Market: By Route Of Administration (2023-2030)
Figure 28 North America Sarcopenia Treatment Market: By Route Of Administration (2023-2030)
Figure 29 North America Sarcopenia Treatment Market: Lifeline Curve
Figure 30 North America Sarcopenia Treatment Market: By Gender, 2022
Figure 31 North America Sarcopenia Treatment Market: By Gender, 2023-2030 (Usd Thousand)
Figure 32 North America Sarcopenia Treatment Market: By Gender, Cagr (2023-2030)
Figure 33 North America Sarcopenia Treatment Market: By Gender, Lifeline Curve
Figure 34 North America Sarcopenia Treatment Market: By End User, 2022
Figure 35 North America Sarcopenia Treatment Market: By End User, 2023-2030 (Usd Thousand)
Figure 36 North America Sarcopenia Treatment Market: By End User, Cagr (2023-2030)
Figure 37 North America Sarcopenia Treatment Market: By End User, Lifeline Curve
Figure 38 North America Sarcopenia Treatment Market: By Distribution Channel, 2022
Figure 39 North America Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 40 North America Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 41 North America Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 42 North America Sarcopenia Treatment Market: Snapshot (2022)
Figure 43 North America Sarcopenia Treatment Marketstructural Health Monitoring Market: Company Share 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us